Harnessing DNA-induced immune responses for improving cancer vaccines

References

• Germain RN, Stefanová I. The dynamics of T cell receptor signaling: complex orchestration and the key roles of tempo and cooperation. Annu Rev Immunol 1999; 17:467 - 522; http://dx.doi.org/10.1146/annurev.immunol.17.1.467; PMID: 10358766
   PubMed Web of Science ®Google Scholar
• Mellman I, Steinman RM. Dendritic cells: specialized and regulated antigen processing machines. Cell 2001; 106:255 - 8; http://dx.doi.org/10.1016/S0092-8674(01)00449-4; PMID: 11509172
   PubMed Web of Science ®Google Scholar
• Lambert PHLM, Liu M, Siegrist CA. Can successful vaccines teach us how to induce efficient protective immune responses?. Nat Med 2005; 11:Suppl S54 - 62; http://dx.doi.org/10.1038/nm1216; PMID: 15812491
   PubMed Web of Science ®Google Scholar
• Jenner E. Two cases of Small-Pox Infection communicated to the Fœtus in Utero under peculiar circumstances, with additional remarks. Med Chir Trans 1809; 1:271 - 7; PMID: 20895118
   PubMedGoogle Scholar
• Gaucher D, Therrien R, Kettaf N, Angermann BR, Boucher G, Filali-Mouhim A, et al. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J Exp Med 2008; 205:3119 - 31; http://dx.doi.org/10.1084/jem.20082292; PMID: 19047440
   PubMed Web of Science ®Google Scholar
• Querec T, Bennouna S, Alkan S, Laouar Y, Gorden K, Flavell R, et al. Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J Exp Med 2006; 203:413 - 24; http://dx.doi.org/10.1084/jem.20051720; PMID: 16461338
   PubMed Web of Science ®Google Scholar
• Kumar H, Kawai T, Akira S. Pathogen recognition in the innate immune response. Biochem J 2009; 420:1 - 16; http://dx.doi.org/10.1042/BJ20090272; PMID: 19382893
   PubMed Web of Science ®Google Scholar
• Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature 2007; 449:819 - 26; http://dx.doi.org/10.1038/nature06246; PMID: 17943118
   PubMed Web of Science ®Google Scholar
• Fox JL, Klass M. Antigens produced by recombinant DNA technology. Clin Chem 1989; 35:1838 - 42; PMID: 2673579
   PubMed Web of Science ®Google Scholar
• Valenzuela P, Medina A, Rutter WJ, Ammerer G, Hall BD. Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature 1982; 298:347 - 50; http://dx.doi.org/10.1038/298347a0; PMID: 7045698
   PubMed Web of Science ®Google Scholar
• Stephenne J. Recombinant versus plasma-derived hepatitis B vaccines: issues of safety, immunogenicity and cost-effectiveness. Vaccine 1988; 6:299 - 303; http://dx.doi.org/10.1016/0264-410X(88)90173-9; PMID: 2973187
   PubMed Web of Science ®Google Scholar
• Paavonen J, Jenkins D, Bosch FX, Naud P, Salmerón J, Wheeler CM, et al, HPV PATRICIA study group. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet 2007; 369:2161 - 70; http://dx.doi.org/10.1016/S0140-6736(07)60946-5; PMID: 17602732
   PubMed Web of Science ®Google Scholar
• Tang DC, DeVit M, Johnston SA. Genetic immunization is a simple method for eliciting an immune response. Nature 1992; 356:152 - 4; http://dx.doi.org/10.1038/356152a0; PMID: 1545867
   PubMed Web of Science ®Google Scholar
• Ulmer JBDJ, Donnelly JJ, Parker SE, Rhodes GH, Felgner PL, Dwarki VJ, et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993; 259:1745 - 9; http://dx.doi.org/10.1126/science.8456302; PMID: 8456302
   PubMed Web of Science ®Google Scholar
• Fynan EFWR, Webster RG, Fuller DH, Haynes JR, Santoro JC, Robinson HL. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc Natl Acad Sci U S A 1993; 90:11478 - 82; http://dx.doi.org/10.1073/pnas.90.24.11478; PMID: 8265577
   PubMed Web of Science ®Google Scholar
• Gurunathan S, Klinman DM, Seder RA. DNA vaccines: immunology, application, and optimization*. Annu Rev Immunol 2000; 18:927 - 74; http://dx.doi.org/10.1146/annurev.immunol.18.1.927; PMID: 10837079
   PubMed Web of Science ®Google Scholar
• Lu S, Wang S, Grimes-Serrano JM. Current progress of DNA vaccine studies in humans. Expert Rev Vaccines 2008; 7:175 - 91; http://dx.doi.org/10.1586/14760584.7.2.175; PMID: 18324888
   PubMed Web of Science ®Google Scholar
• Klinman DM, Yamshchikov G, Ishigatsubo Y. Contribution of CpG motifs to the immunogenicity of DNA vaccines. J Immunol 1997; 158:3635 - 9; PMID: 9103425
   PubMed Web of Science ®Google Scholar
• Doe B, Selby M, Barnett S, Baenziger J, Walker CM. Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc Natl Acad Sci U S A 1996; 93:8578 - 83; http://dx.doi.org/10.1073/pnas.93.16.8578; PMID: 8710913
   PubMed Web of Science ®Google Scholar
• Corr M, Lee DJ, Carson DA, Tighe H. Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J Exp Med 1996; 184:1555 - 60; http://dx.doi.org/10.1084/jem.184.4.1555; PMID: 8879229
   PubMed Web of Science ®Google Scholar
• Marichal T, Ohata K, Bedoret D, Mesnil C, Sabatel C, Kobiyama K, et al. DNA released from dying host cells mediates aluminum adjuvant activity. Nat Med 2011; 17:996 - 1002; http://dx.doi.org/10.1038/nm.2403; PMID: 21765404
   PubMed Web of Science ®Google Scholar
• Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408:740 - 5; http://dx.doi.org/10.1038/35047123; PMID: 11130078
   PubMed Web of Science ®Google Scholar
• Krieg AM. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 2002; 20:709 - 60; http://dx.doi.org/10.1146/annurev.immunol.20.100301.064842; PMID: 11861616
   PubMed Web of Science ®Google Scholar
• Spies B, Hochrein H, Vabulas M, Huster K, Busch DH, Schmitz F, et al. Vaccination with plasmid DNA activates dendritic cells via Toll-like receptor 9 (TLR9) but functions in TLR9-deficient mice. J Immunol 2003; 171:5908 - 12; PMID: 14634101
   PubMed Web of Science ®Google Scholar
• Takaoka A, Wang Z, Choi MK, Yanai H, Negishi H, Ban T, et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 2007; 448:501 - 5; http://dx.doi.org/10.1038/nature06013; PMID: 17618271
   PubMed Web of Science ®Google Scholar
• Bürckstümmer T, Baumann C, Blüml S, Dixit E, Dürnberger G, Jahn H, et al. An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat Immunol 2009; 10:266 - 72; http://dx.doi.org/10.1038/ni.1702; PMID: 19158679
   PubMed Web of Science ®Google Scholar
• Hornung V, Ablasser A, Charrel-Dennis M, Bauernfeind F, Horvath G, Caffrey DR, et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 2009; 458:514 - 8; http://dx.doi.org/10.1038/nature07725; PMID: 19158675
   PubMed Web of Science ®Google Scholar
• Unterholzner L, Keating SE, Baran M, Horan KA, Jensen SB, Sharma S, et al. IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol 2010; 11:997 - 1004; http://dx.doi.org/10.1038/ni.1932; PMID: 20890285
   PubMed Web of Science ®Google Scholar
• Yang P, An H, Liu X, Wen M, Zheng Y, Rui Y, et al. The cytosolic nucleic acid sensor LRRFIP1 mediates the production of type I interferon via a beta-catenin-dependent pathway. Nat Immunol 2010; 11:487 - 94; http://dx.doi.org/10.1038/ni.1876; PMID: 20453844
   PubMed Web of Science ®Google Scholar
• Ablasser A, Bauernfeind F, Hartmann G, Latz E, Fitzgerald KA, Hornung V. RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat Immunol 2009; 10:1065 - 72; http://dx.doi.org/10.1038/ni.1779; PMID: 19609254
   PubMed Web of Science ®Google Scholar
• Chiu YH, Macmillan JB, Chen ZJ. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 2009; 138:576 - 91; http://dx.doi.org/10.1016/j.cell.2009.06.015; PMID: 19631370
   PubMed Web of Science ®Google Scholar
• Wang Z, Choi MK, Ban T, Yanai H, Negishi H, Lu Y, et al. Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules. Proc Natl Acad Sci U S A 2008; 105:5477 - 82; http://dx.doi.org/10.1073/pnas.0801295105; PMID: 18375758
   PubMed Web of Science ®Google Scholar
• Kaiser WJ, Upton JW, Mocarski ES. Receptor-interacting protein homotypic interaction motif-dependent control of NF-kappa B activation via the DNA-dependent activator of IFN regulatory factors. J Immunol 2008; 181:6427 - 34; PMID: 18941233
   PubMed Web of Science ®Google Scholar
• Fernandes-Alnemri T, Yu JW, Datta P, Wu J, Alnemri ES. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 2009; 458:509 - 13; http://dx.doi.org/10.1038/nature07710; PMID: 19158676
   PubMed Web of Science ®Google Scholar
• Takeshita F, Tanaka T, Matsuda T, Tozuka M, Kobiyama K, Saha S, et al. Toll-like receptor adaptor molecules enhance DNA-raised adaptive immune responses against influenza and tumors through activation of innate immunity. J Virol 2006; 80:6218 - 24; http://dx.doi.org/10.1128/JVI.00121-06; PMID: 16775309
   PubMed Web of Science ®Google Scholar
• Shirota H, Ishii KJ, Takakuwa H, Klinman DM. Contribution of interferon-beta to the immune activation induced by double-stranded DNA. Immunology 2006; 118:302 - 10; http://dx.doi.org/10.1111/j.1365-2567.2006.02367.x; PMID: 16827891
   PubMed Web of Science ®Google Scholar
• Lladser A, Mougiakakos D, Tufvesson H, Ligtenberg MA, Quest AF, Kiessling R, et al. DAI (DLM-1/ZBP1) as a genetic adjuvant for DNA vaccines that promotes effective antitumor CTL immunity. Mol Ther 2011; 19:594 - 601; http://dx.doi.org/10.1038/mt.2010.268; PMID: 21157438
   PubMed Web of Science ®Google Scholar
• Kortylewski M, Kujawski M, Herrmann A, Yang C, Wang L, Liu Y, et al. Toll-like receptor 9 activation of signal transducer and activator of transcription 3 constrains its agonist-based immunotherapy. Cancer Res 2009; 69:2497 - 505; http://dx.doi.org/10.1158/0008-5472.CAN-08-3031; PMID: 19258507
   PubMed Web of Science ®Google Scholar
• Miles K, Heaney J, Sibinska Z, Salter D, Savill J, Gray D, et al. A tolerogenic role for Toll-like receptor 9 is revealed by B-cell interaction with DNA complexes expressed on apoptotic cells. Proc Natl Acad Sci U S A 2012; 109:887 - 92; http://dx.doi.org/10.1073/pnas.1109173109; PMID: 22207622
   PubMed Web of Science ®Google Scholar
• Veeranki S, Duan X, Panchanathan R, Liu H, Choubey D. IFI16 protein mediates the anti-inflammatory actions of the type-I interferons through suppression of activation of caspase-1 by inflammasomes. PLoS One 2011; 6:e27040; http://dx.doi.org/10.1371/journal.pone.0027040; PMID: 22046441
   PubMed Web of Science ®Google Scholar
• Schirmbeck R, Böhm W, Ando K, Chisari FV, Reimann J. Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice. J Virol 1995; 69:5929 - 34; PMID: 7666497
   PubMed Web of Science ®Google Scholar
• Kuhröber A, Wild J, Pudollek HP, Chisari FV, Reimann J. DNA vaccination with plasmids encoding the intracellular (HBcAg) or secreted (HBeAg) form of the core protein of hepatitis B virus primes T cell responses to two overlapping Kb- and Kd-restricted epitopes. Int Immunol 1997; 9:1203 - 12; http://dx.doi.org/10.1093/intimm/9.8.1203; PMID: 9263018
   PubMed Web of Science ®Google Scholar
• Zhang W, Dong SF, Sun SH, Wang Y, Li GD, Qu D. Coimmunization with IL-15 plasmid enhances the longevity of CD8 T cells induced by DNA encoding hepatitis B virus core antigen. World J Gastroenterol 2006; 12:4727 - 35; PMID: 16937447
   PubMed Web of Science ®Google Scholar
• Shiver JW, Perry HC, Davies ME, Freed DC, Liu MA. Cytotoxic T lymphocyte and helper T cell responses following HIV polynucleotide vaccination. Ann N Y Acad Sci 1995; 772:198 - 208; http://dx.doi.org/10.1111/j.1749-6632.1995.tb44745.x; PMID: 8546393
   PubMed Web of Science ®Google Scholar
• Boyer JD, Chattergoon M, Shah A, Ginsberg R, MacGregor RR, Weiner DB. HIV-1 DNA based vaccine induces a CD8 mediated cross-clade CTL response. Dev Biol Stand 1998; 95:147 - 53; PMID: 9855425
   PubMedGoogle Scholar
• Uchijima M, Yoshida A, Nagata T, Koide Y. Optimization of codon usage of plasmid DNA vaccine is required for the effective MHC class I-restricted T cell responses against an intracellular bacterium. J Immunol 1998; 161:5594 - 9; PMID: 9820537
   PubMed Web of Science ®Google Scholar
• Schirmbeck R, Riedl P, Kupferschmitt M, Wegenka U, Hauser H, Rice J, et al. Priming protective CD8 T cell immunity by DNA vaccines encoding chimeric, stress protein-capturing tumor-associated antigen. J Immunol 2006; 177:1534 - 42; PMID: 16849460
   PubMed Web of Science ®Google Scholar
• Vasan S, Hurley A, Schlesinger SJ, Hannaman D, Gardiner DF, Dugin DP, et al. In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers. PLoS One 2011; 6:e19252; http://dx.doi.org/10.1371/journal.pone.0019252; PMID: 21603651
   PubMed Web of Science ®Google Scholar
• Adams MD, Celniker SE, Holt RA, Evans CA, Gocayne JD, Amanatides PG, et al. The genome sequence of Drosophila melanogaster. Science 2000; 287:2185 - 95; http://dx.doi.org/10.1126/science.287.5461.2185; PMID: 10731132
   PubMed Web of Science ®Google Scholar
• Kang Y, Zheng G, Chen A, Wang J, Hu Y, Li J, et al. Tolerogenic DNA vaccine for prevention of autoimmune ovarian disease. Immunol Invest 2012; 41:249 - 60; http://dx.doi.org/10.3109/08820139.2011.622828; PMID: 22221010
   PubMed Web of Science ®Google Scholar
• Nakano O, Sato M, Naito Y, Suzuki K, Orikasa S, Aizawa M, et al. Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity. Cancer Res 2001; 61:5132 - 6; PMID: 11431351
   PubMed Web of Science ®Google Scholar
• Yanai H, Ban T, Wang Z, Choi MK, Kawamura T, Negishi H, et al. HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature 2009; 462:99 - 103; http://dx.doi.org/10.1038/nature08512; PMID: 19890330
   PubMed Web of Science ®Google Scholar
• Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G, et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 2003; 348:203 - 13; http://dx.doi.org/10.1056/NEJMoa020177; PMID: 12529460
   PubMed Web of Science ®Google Scholar
• Rosenberg SA, Dudley ME. Adoptive cell therapy for the treatment of patients with metastatic melanoma. Curr Opin Immunol 2009; 21:233 - 40; http://dx.doi.org/10.1016/j.coi.2009.03.002; PMID: 19304471
   PubMed Web of Science ®Google Scholar
• Boon T, van Baren N. Immunosurveillance against cancer and immunotherapy--synergy or antagonism?. N Engl J Med 2003; 348:252 - 4; http://dx.doi.org/10.1056/NEJMe020165; PMID: 12529468
   PubMed Web of Science ®Google Scholar
• Germeau C, Ma W, Schiavetti F, Lurquin C, Henry E, Vigneron N, et al. High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens. J Exp Med 2005; 201:241 - 8; http://dx.doi.org/10.1084/jem.20041379; PMID: 15657293
   PubMed Web of Science ®Google Scholar
• Boon T, van der Bruggen P. Human tumor antigens recognized by T lymphocytes. J Exp Med 1996; 183:725 - 9; http://dx.doi.org/10.1084/jem.183.3.725; PMID: 8642276
   PubMed Web of Science ®Google Scholar
• Marshall J. Carcinoembryonic antigen-based vaccines. Semin Oncol 2003; 30:Suppl 8 30 - 6; http://dx.doi.org/10.1016/S0093-7754(03)00233-1; PMID: 12881810
   PubMed Web of Science ®Google Scholar
• Renard V, Leach DR. Perspectives on the development of a therapeutic HER-2 cancer vaccine. Vaccine 2007; 25:Suppl 2 B17 - 23; http://dx.doi.org/10.1016/j.vaccine.2007.05.060; PMID: 17630057
   PubMedGoogle Scholar
• Zendman AJ, Ruiter DJ, Van Muijen GN. Cancer/testis-associated genes: identification, expression profile, and putative function. J Cell Physiol 2003; 194:272 - 88; http://dx.doi.org/10.1002/jcp.10215; PMID: 12548548
   PubMed Web of Science ®Google Scholar
• Robbins PF, el-Gamil M, Kawakami Y, Stevens E, Yannelli JR, Rosenberg SA. Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy. Cancer Res 1994; 54:3124 - 6; PMID: 8205528
   PubMed Web of Science ®Google Scholar
• Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol 1994; 151:1283 - 90; PMID: 7512659
   PubMed Web of Science ®Google Scholar
• Saaty TL. The analytic hierarchy process: planning, priority setting, resource allocation. McGraw-Hill International Book Co., 1980.
   Google Scholar
• Cheever MA, Allison JP, Ferris AS, Finn OJ, Hastings BM, Hecht TT, et al. The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research. Clin Cancer Res 2009; 15:5323 - 37; http://dx.doi.org/10.1158/1078-0432.CCR-09-0737; PMID: 19723653
   PubMed Web of Science ®Google Scholar
• Klebanoff CA, Acquavella N, Yu Z, Restifo NP. Therapeutic cancer vaccines: are we there yet?. Immunol Rev 2011; 239:27 - 44; http://dx.doi.org/10.1111/j.1600-065X.2010.00979.x; PMID: 21198663
   PubMed Web of Science ®Google Scholar
• Stritesky GL, Jameson SC, Hogquist KA. Selection of self-reactive T cells in the thymus. Annu Rev Immunol 2012; 30:95 - 114; http://dx.doi.org/10.1146/annurev-immunol-020711-075035; PMID: 22149933
   PubMed Web of Science ®Google Scholar
• Josefowicz SZ, Lu LF, Rudensky AY. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol 2012; 30:531 - 64; http://dx.doi.org/10.1146/annurev.immunol.25.022106.141623; PMID: 22224781
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Sakaguchi N, Shimizu J, Yamazaki S, Sakihama T, Itoh M, et al. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 2001; 182:18 - 32; http://dx.doi.org/10.1034/j.1600-065X.2001.1820102.x; PMID: 11722621
   PubMed Web of Science ®Google Scholar
• Yagi H, Nomura T, Nakamura K, Yamazaki S, Kitawaki T, Hori S, et al. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int Immunol 2004; 16:1643 - 56; http://dx.doi.org/10.1093/intimm/dxh165; PMID: 15466453
   PubMed Web of Science ®Google Scholar
• Mittendorf EA, Sharma P. Mechanisms of T-cell inhibition: implications for cancer immunotherapy. Expert Rev Vaccines 2010; 9:89 - 105; http://dx.doi.org/10.1586/erv.09.144; PMID: 20021308
   PubMed Web of Science ®Google Scholar
• Porta C, Larghi P, Rimoldi M, Totaro MG, Allavena P, Mantovani A, et al. Cellular and molecular pathways linking inflammation and cancer. Immunobiology 2009; 214:761 - 77; http://dx.doi.org/10.1016/j.imbio.2009.06.014; PMID: 19616341
   PubMed Web of Science ®Google Scholar
• Ostrand-Rosenberg S, Sinha P. Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol 2009; 182:4499 - 506; http://dx.doi.org/10.4049/jimmunol.0802740; PMID: 19342621
   PubMed Web of Science ®Google Scholar
• Kusmartsev S, Gabrilovich DI. Effect of tumor-derived cytokines and growth factors on differentiation and immune suppressive features of myeloid cells in cancer. Cancer Metastasis Rev 2006; 25:323 - 31; http://dx.doi.org/10.1007/s10555-006-9002-6; PMID: 16983515
   PubMed Web of Science ®Google Scholar
• Gallina G, Dolcetti L, Serafini P, De Santo C, Marigo I, Colombo MP, et al. Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. J Clin Invest 2006; 116:2777 - 90; http://dx.doi.org/10.1172/JCI28828; PMID: 17016559
   PubMed Web of Science ®Google Scholar
• Diaz-Montero CM, Salem ML, Nishimura MI, Garrett-Mayer E, Cole DJ, Montero AJ. Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy. Cancer Immunol Immunother 2009; 58:49 - 59; http://dx.doi.org/10.1007/s00262-008-0523-4; PMID: 18446337
   PubMed Web of Science ®Google Scholar
• Almand B, Clark JI, Nikitina E, van Beynen J, English NR, Knight SC, et al. Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J Immunol 2001; 166:678 - 89; PMID: 11123353
   PubMed Web of Science ®Google Scholar
• Corzo CA, Cotter MJ, Cheng P, Cheng F, Kusmartsev S, Sotomayor E, et al. Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells. J Immunol 2009; 182:5693 - 701; http://dx.doi.org/10.4049/jimmunol.0900092; PMID: 19380816
   PubMed Web of Science ®Google Scholar
• Srivastava MK, Sinha P, Clements VK, Rodriguez P, Ostrand-Rosenberg S. Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine. Cancer Res 2010; 70:68 - 77; http://dx.doi.org/10.1158/0008-5472.CAN-09-2587; PMID: 20028852
   PubMed Web of Science ®Google Scholar
• Lechner MG, Liebertz DJ, Epstein AL. Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells. J Immunol 2010; 185:2273 - 84; http://dx.doi.org/10.4049/jimmunol.1000901; PMID: 20644162
   PubMed Web of Science ®Google Scholar
• Peng S, Kim TW, Lee JH, Yang M, He L, Hung CF, et al. Vaccination with dendritic cells transfected with BAK and BAX siRNA enhances antigen-specific immune responses by prolonging dendritic cell life. Hum Gene Ther 2005; 16:584 - 93; http://dx.doi.org/10.1089/hum.2005.16.584; PMID: 15916483
   PubMed Web of Science ®Google Scholar
• Whiteside TL. What are regulatory T cells (Treg) regulating in cancer and why?. Semin Cancer Biol 2012; 22:327 - 34; http://dx.doi.org/10.1016/j.semcancer.2012.03.004; PMID: 22465232
   PubMed Web of Science ®Google Scholar
• Cheng HH, Tseng GY, Yang HB, Wang HJ, Lin HJ, Wang WC. Increased numbers of Foxp3-positive regulatory T cells in gastritis, peptic ulcer and gastric adenocarcinoma. World J Gastroenterol 2012; 18:34 - 43; http://dx.doi.org/10.3748/wjg.v18.i1.34; PMID: 22228968
   PubMed Web of Science ®Google Scholar
• Wolchok JD, Yuan J, Houghton AN, Gallardo HF, Rasalan TS, Wang J, et al. Safety and immunogenicity of tyrosinase DNA vaccines in patients with melanoma. Mol Ther 2007; 15:2044 - 50; http://dx.doi.org/10.1038/sj.mt.6300290; PMID: 17726460
   PubMed Web of Science ®Google Scholar
• Qin FX. Dynamic behavior and function of Foxp3+ regulatory T cells in tumor bearing host. Cell Mol Immunol 2009; 6:3 - 13; http://dx.doi.org/10.1038/cmi.2009.2; PMID: 19254475
   PubMed Web of Science ®Google Scholar
• Heinze E, Baldwin S, Chan G, Hansen J, Song J, Clements D, et al. Antibody-mediated FOXP3 protein therapy induces apoptosis in cancer cells in vitro and inhibits metastasis in vivo. Int J Oncol 2009; 35:167 - 73; PMID: 19513564
   PubMed Web of Science ®Google Scholar
• Paust S, Lu L, McCarty N, Cantor H. Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc Natl Acad Sci U S A 2004; 101:10398 - 403; http://dx.doi.org/10.1073/pnas.0403342101; PMID: 15235129
   PubMed Web of Science ®Google Scholar
• Fallarino F, Grohmann U, Hwang KW, Orabona C, Vacca C, Bianchi R, et al. Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol 2003; 4:1206 - 12; http://dx.doi.org/10.1038/ni1003; PMID: 14578884
   PubMed Web of Science ®Google Scholar
• Collison LW, Chaturvedi V, Henderson AL, Giacomin PR, Guy C, Bankoti J, et al. IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol 2010; 11:1093 - 101; http://dx.doi.org/10.1038/ni.1952; PMID: 20953201
   PubMed Web of Science ®Google Scholar
• Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002; 23:549 - 55; http://dx.doi.org/10.1016/S1471-4906(02)02302-5; PMID: 12401408
   PubMed Web of Science ®Google Scholar
• Baay M, Brouwer A, Pauwels P, Peeters M, Lardon F. Tumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapy. Clin Dev Immunol 2011; 2011:565187; http://dx.doi.org/10.1155/2011/565187; PMID: 22162712
   PubMed Web of Science ®Google Scholar
• Solinas G, Germano G, Mantovani A, Allavena P. Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J Leukoc Biol 2009; 86:1065 - 73; http://dx.doi.org/10.1189/jlb.0609385; PMID: 19741157
   PubMed Web of Science ®Google Scholar
• Erreni M, Mantovani A, Allavena P. Tumor-associated Macrophages (TAM) and Inflammation in Colorectal Cancer. Cancer Microenviron 2011; 4:141 - 54; http://dx.doi.org/10.1007/s12307-010-0052-5; PMID: 21909876
   PubMedGoogle Scholar
• Kawahara A, Hattori S, Akiba J, Nakashima K, Taira T, Watari K, et al. Infiltration of thymidine phosphorylase-positive macrophages is closely associated with tumor angiogenesis and survival in intestinal type gastric cancer. Oncol Rep 2010; 24:405 - 15; http://dx.doi.org/10.3892/or_00000873; PMID: 20596627
   PubMed Web of Science ®Google Scholar
• Ryder M, Ghossein RA, Ricarte-Filho JC, Knauf JA, Fagin JA. Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer. Endocr Relat Cancer 2008; 15:1069 - 74; http://dx.doi.org/10.1677/ERC-08-0036; PMID: 18719091
   PubMed Web of Science ®Google Scholar
• Kurahara H, Shinchi H, Mataki Y, Maemura K, Noma H, Kubo F, et al. Significance of M2-polarized tumor-associated macrophage in pancreatic cancer. J Surg Res 2011; 167:e211 - 9; http://dx.doi.org/10.1016/j.jss.2009.05.026; PMID: 19765725
   PubMed Web of Science ®Google Scholar
• Guan Y, Zhang M, Li Y, Cao W, Ji M, Liu Y. Vaccination with IA-2 autoantigen can prevent late prediabetic nonobese diabetic mice from developing diabetes mellitus. Diabetes Res Clin Pract 2012; 95:93 - 7; http://dx.doi.org/10.1016/j.diabres.2011.09.019; PMID: 22004942
   PubMed Web of Science ®Google Scholar
• Liu J, Zhang N, Li Q, Zhang W, Ke F, Leng Q, et al. Tumor-associated macrophages recruit CCR6+ regulatory T cells and promote the development of colorectal cancer via enhancing CCL20 production in mice. PLoS One 2011; 6:e19495; http://dx.doi.org/10.1371/journal.pone.0019495; PMID: 21559338
   PubMed Web of Science ®Google Scholar
• Hawkins RE, Zhu D, Ovecka M, Winter G, Hamblin TJ, Long A, et al. Idiotypic vaccination against human B-cell lymphoma. Rescue of variable region gene sequences from biopsy material for assembly as single-chain Fv personal vaccines. Blood 1994; 83:3279 - 88; PMID: 8193363
   PubMed Web of Science ®Google Scholar
• Rice J, Ottensmeier CH, Stevenson FK. DNA vaccines: precision tools for activating effective immunity against cancer. Nat Rev Cancer 2008; 8:108 - 20; http://dx.doi.org/10.1038/nrc2326; PMID: 18219306
   PubMed Web of Science ®Google Scholar
• Timmerman JM, Singh G, Hermanson G, Hobart P, Czerwinski DK, Taidi B, et al. Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma. Cancer Res 2002; 62:5845 - 52; PMID: 12384547
   PubMed Web of Science ®Google Scholar
• Disis ML, Schiffman K, Guthrie K, Salazar LG, Knutson KL, Goodell V, et al. Effect of dose on immune response in patients vaccinated with an her-2/neu intracellular domain protein--based vaccine. J Clin Oncol 2004; 22:1916 - 25; http://dx.doi.org/10.1200/JCO.2004.09.005; PMID: 15143085
   PubMed Web of Science ®Google Scholar
• Perales MA, Yuan J, Powel S, Gallardo HF, Rasalan TS, Gonzalez C, et al. Phase I/II study of GM-CSF DNA as an adjuvant for a multipeptide cancer vaccine in patients with advanced melanoma. Mol Ther 2008; 16:2022 - 9; http://dx.doi.org/10.1038/mt.2008.196; PMID: 18797450
   PubMed Web of Science ®Google Scholar
• Trimble CL, Peng S, Kos F, Gravitt P, Viscidi R, Sugar E, et al. A phase I trial of a human papillomavirus DNA vaccine for HPV16+ cervical intraepithelial neoplasia 2/3. Clin Cancer Res 2009; 15:361 - 7; http://dx.doi.org/10.1158/1078-0432.CCR-08-1725; PMID: 19118066
   PubMed Web of Science ®Google Scholar
• Low L, Mander A, McCann K, Dearnaley D, Tjelle T, Mathiesen I, et al. DNA vaccination with electroporation induces increased antibody responses in patients with prostate cancer. Hum Gene Ther 2009; 20:1269 - 78; http://dx.doi.org/10.1089/hum.2009.067; PMID: 19619001
   PubMed Web of Science ®Google Scholar
• McNeel DG, Dunphy EJ, Davies JG, Frye TP, Johnson LE, Staab MJ, et al. Safety and immunological efficacy of a DNA vaccine encoding prostatic acid phosphatase in patients with stage D0 prostate cancer. J Clin Oncol 2009; 27:4047 - 54; http://dx.doi.org/10.1200/JCO.2008.19.9968; PMID: 19636017
   PubMed Web of Science ®Google Scholar
• Kutzler MA, Weiner DB. DNA vaccines: ready for prime time?. Nat Rev Genet 2008; 9:776 - 88; http://dx.doi.org/10.1038/nrg2432; PMID: 18781156
   PubMed Web of Science ®Google Scholar
• Jechlinger W. Optimization and delivery of plasmid DNA for vaccination. Expert Rev Vaccines 2006; 5:803 - 25; http://dx.doi.org/10.1586/14760584.5.6.803; PMID: 17184219
   PubMed Web of Science ®Google Scholar
• Ginsberg BA, Gallardo HF, Rasalan TS, Adamow M, Mu Z, Tandon S, et al. Immunologic response to xenogeneic gp100 DNA in melanoma patients: comparison of particle-mediated epidermal delivery with intramuscular injection. Clin Cancer Res 2010; 16:4057 - 65; http://dx.doi.org/10.1158/1078-0432.CCR-10-1093; PMID: 20647477
   PubMed Web of Science ®Google Scholar
• Pavlenko M, Roos AK, Lundqvist A, Palmborg A, Miller AM, Ozenci V, et al. A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer. Br J Cancer 2004; 91:688 - 94; PMID: 15280930
   PubMed Web of Science ®Google Scholar
• Yuan J, Ku GY, Gallardo HF, Orlandi F, Manukian G, Rasalan TS, et al. Safety and immunogenicity of a human and mouse gp100 DNA vaccine in a phase I trial of patients with melanoma. Cancer Immun 2009; 9:5; PMID: 19496531
   PubMedGoogle Scholar
• Walpole SC, Prieto-Merino D, Edwards P, Cleland J, Stevens G, Roberts I. The weight of nations: an estimation of adult human biomass. BMC Public Health 2012; 12:439; http://dx.doi.org/10.1186/1471-2458-12-439; PMID: 22709383
   PubMed Web of Science ®Google Scholar
• Norell H, Poschke I, Charo J, Wei WZ, Erskine C, Piechocki MP, et al. Vaccination with a plasmid DNA encoding HER-2/neu together with low doses of GM-CSF and IL-2 in patients with metastatic breast carcinoma: a pilot clinical trial. J Transl Med 2010; 8:53; http://dx.doi.org/10.1186/1479-5876-8-53; PMID: 20529245
   PubMed Web of Science ®Google Scholar
• Luxembourg A, Evans CF, Hannaman D. Electroporation-based DNA immunisation: translation to the clinic. Expert Opin Biol Ther 2007; 7:1647 - 64; http://dx.doi.org/10.1517/14712598.7.11.1647; PMID: 17961089
   PubMed Web of Science ®Google Scholar
• Stoitzner PSF, Sparber F, Tripp CH. Langerhans cells as targets for immunotherapy against skin cancer. Immunol Cell Biol 2010; 88:431 - 7; http://dx.doi.org/10.1038/icb.2010.31; PMID: 20351746
   PubMed Web of Science ®Google Scholar
• Arnou RIG, Icardi G, De Decker M, Ambrozaitis A, Kazek MP, Weber F, et al. Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study. Vaccine 2009; 27:7304 - 12; http://dx.doi.org/10.1016/j.vaccine.2009.10.033; PMID: 19849996
   PubMed Web of Science ®Google Scholar
• Neumann E, Rosenheck K. Permeability changes induced by electric impulses in vesicular membranes. J Membr Biol 1972; 10:279 - 90; http://dx.doi.org/10.1007/BF01867861; PMID: 4667921
   PubMed Web of Science ®Google Scholar
• Gabriel BJT, Teissié J. Control by electrical parameters of short- and long-term cell death resulting from electropermeabilization of Chinese hamster ovary cells. Biochim Biophys Acta 1995; 1266:171 - 8; http://dx.doi.org/10.1016/0167-4889(95)00021-J; PMID: 7742383
   PubMed Web of Science ®Google Scholar
• Mir LMGL, Glass LF, Sersa G, Teissié J, Domenge C, Miklavcic D, et al. Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer 1998; 77:2336 - 42; http://dx.doi.org/10.1038/bjc.1998.388; PMID: 9649155
   PubMed Web of Science ®Google Scholar
• E. Neumann MS-R. Y. Wang, Ph. Hofschneider. Gene transfer into mouse lyoma by electroporation in high electric field. EMBO J 1982; 1:841 - 5; PMID: 6329708
   PubMed Web of Science ®Google Scholar
• Heller RJM, Jaroszeski MJ, Glass LF, Messina JL, Rapaport DP, DeConti RC, et al. Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer 1996; 77:964 - 71; http://dx.doi.org/10.1002/(SICI)1097-0142(19960301)77:5<964::AID-CNCR24>3.0.CO;2-0; PMID: 8608491
   PubMed Web of Science ®Google Scholar
• Mir LMBM, Belehradek M, Domenge C, Orlowski S, Poddevin B, Belehradek J Jr., et al. [Electrochemotherapy, a new antitumor treatment: first clinical trial]. C R Acad Sci III 1991; 313:613 - 8; PMID: 1723647
   PubMed Web of Science ®Google Scholar
• Heller RJM, Jaroszeski M, Atkin A, Moradpour D, Gilbert R, Wands J, et al. In vivo gene electroinjection and expression in rat liver. FEBS Lett 1996; 389:225 - 8; http://dx.doi.org/10.1016/0014-5793(96)00590-X; PMID: 8766704
   PubMed Web of Science ®Google Scholar
• Suzuki TSB, Shin BC, Fujikura K, Matsuzaki T, Takata K. Direct gene transfer into rat liver cells by in vivo electroporation. FEBS Lett 1998; 425:436 - 40; http://dx.doi.org/10.1016/S0014-5793(98)00284-1; PMID: 9563509
   PubMed Web of Science ®Google Scholar
• Camille Boutin SD, et al. Efficient In Vivo Electroporation of the Postnatal Rodent Forebrain. PLoS ONE 2008;
   PubMed Web of Science ®Google Scholar
• Xue-Feng Ding Y-QZ, et al. Efficient Gene Transfer into Neonatal Mouse Brain Using Electroporation. Neurochem Res 2012; 0 - 6
   Google Scholar
• Blair-Parks KWB, Weston BC, Dean DA. High-level gene transfer to the cornea using electroporation. J Gene Med 2002; 4:92 - 100; http://dx.doi.org/10.1002/jgm.231; PMID: 11828392
   PubMed Web of Science ®Google Scholar
• Kang Y, Zhao J, Liu Y, Chen A, Zheng G, Yu Y, et al. FK506 as an adjuvant of tolerogenic DNA vaccination for the prevention of experimental autoimmune encephalomyelitis. J Gene Med 2009; 11:1064 - 70; http://dx.doi.org/10.1002/jgm.1387; PMID: 19688809
   PubMed Web of Science ®Google Scholar
• Aihara H, Miyazaki J. Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 1998; 16:867 - 70; http://dx.doi.org/10.1038/nbt0998-867; PMID: 9743122
   PubMed Web of Science ®Google Scholar
• Lucas MLHL, Heller L, Coppola D, Heller R. IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma. Mol Ther 2002; 5:668 - 75; http://dx.doi.org/10.1006/mthe.2002.0601; PMID: 12027550
   PubMed Web of Science ®Google Scholar
• Lucas MLHR, Heller R. IL-12 gene therapy using an electrically mediated nonviral approach reduces metastatic growth of melanoma. DNA Cell Biol 2003; 22:755 - 63; http://dx.doi.org/10.1089/104454903322624966; PMID: 14683586
   PubMed Web of Science ®Google Scholar
• Ahlén G, Söderholm J, Tjelle T, Kjeken R, Frelin L, Höglund U, et al. In vivo electroporation enhances the immunogenicity of hepatitis C virus nonstructural 3/4A DNA by increased local DNA uptake, protein expression, inflammation, and infiltration of CD3+ T cells. J Immunol 2007; 179:4741 - 53; PMID: 17878373
   PubMed Web of Science ®Google Scholar
• Babiuk S, Baca-Estrada ME, Foldvari M, Middleton DM, Rabussay D, Widera G, et al. Increased gene expression and inflammatory cell infiltration caused by electroporation are both important for improving the efficacy of DNA vaccines. J Biotechnol 2004; 110:1 - 10; http://dx.doi.org/10.1016/j.jbiotec.2004.01.015; PMID: 15099900
   PubMed Web of Science ®Google Scholar
• Chudley L, McCann K, Mander A, Tjelle T, Campos-Perez J, Godeseth R, et al. DNA fusion-gene vaccination in patients with prostate cancer induces high-frequency CD8(+) T-cell responses and increases PSA doubling time. Cancer Immunol Immunother 2012; In press http://dx.doi.org/10.1007/s00262-012-1270-0; PMID: 22729556
   PubMed Web of Science ®Google Scholar
• Lladser A, Ljungberg K, Tufvesson H, Tazzari M, Roos AK, Quest AF, et al. Intradermal DNA electroporation induces survivin-specific CTLs, suppresses angiogenesis and confers protection against mouse melanoma. Cancer Immunol Immunother 2010; 59:81 - 92; http://dx.doi.org/10.1007/s00262-009-0725-4; PMID: 19526360
   PubMed Web of Science ®Google Scholar
• Roos AK, Moreno S, Leder C, Pavlenko M, King A, Pisa P. Enhancement of cellular immune response to a prostate cancer DNA vaccine by intradermal electroporation. Mol Ther 2006; 13:320 - 7; http://dx.doi.org/10.1016/j.ymthe.2005.08.005; PMID: 16185933
   PubMed Web of Science ®Google Scholar
• Agadjanyan MG, Chattergoon MA, Holterman MJ, Monzavi-Karbassi B, Kim JJ, Dentchev T, et al. Costimulatory molecule immune enhancement in a plasmid vaccine model is regulated in part through the Ig constant-like domain of CD80/86. J Immunol 2003; 171:4311 - 9; PMID: 14530356
   PubMed Web of Science ®Google Scholar
• Kim JJ, Yang JS, Dentchev T, Dang K, Weiner DB. Chemokine gene adjuvants can modulate immune responses induced by DNA vaccines. J Interferon Cytokine Res 2000; 20:487 - 98; http://dx.doi.org/10.1089/10799900050023906; PMID: 10841077
   PubMed Web of Science ®Google Scholar
• Iwasaki A, Stiernholm BJ, Chan AK, Berinstein NL, Barber BH. Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. J Immunol 1997; 158:4591 - 601; PMID: 9144471
   PubMed Web of Science ®Google Scholar
• Querec TD, Akondy RS, Lee EK, Cao W, Nakaya HI, Teuwen D, et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat Immunol 2009; 10:116 - 25; http://dx.doi.org/10.1038/ni.1688; PMID: 19029902
   PubMed Web of Science ®Google Scholar
• Liu MA, Wahren B, Karlsson Hedestam GB. DNA vaccines: recent developments and future possibilities. Hum Gene Ther 2006; 17:1051 - 61; http://dx.doi.org/10.1089/hum.2006.17.1051; PMID: 17032152
   PubMed Web of Science ®Google Scholar
• Fagone P, Shedlock DJ, Bao H, Kawalekar OU, Yan J, Gupta D, et al. Molecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccination. Gene Ther 2011; 18:1070 - 7; http://dx.doi.org/10.1038/gt.2011.59; PMID: 21544096
   PubMed Web of Science ®Google Scholar
• Sasaki S, Amara RR, Yeow WS, Pitha PM, Robinson HL. Regulation of DNA-raised immune responses by cotransfected interferon regulatory factors. J Virol 2002; 76:6652 - 9; http://dx.doi.org/10.1128/JVI.76.13.6652-6659.2002; PMID: 12050378
   PubMed Web of Science ®Google Scholar
• Castaldello A, Sgarbanti M, Marsili G, Brocca-Cofano E, Remoli AL, Caputo A, et al. Interferon regulatory factor-1 acts as a powerful adjuvant in tat DNA based vaccination. J Cell Physiol 2010; 224:702 - 9; http://dx.doi.org/10.1002/jcp.22169; PMID: 20432465
   PubMed Web of Science ®Google Scholar
• Dharmapuri S, Aurisicchio L, Biondo A, Welsh N, Ciliberto G, La Monica N. Antiapoptotic small interfering RNA as potent adjuvant of DNA vaccination in a mouse mammary tumor model. Hum Gene Ther 2009; 20:589 - 97; http://dx.doi.org/10.1089/hum.2008.210; PMID: 19222350
   PubMed Web of Science ®Google Scholar
• Shen L, Evel-Kabler K, Strube R, Chen SY. Silencing of SOCS1 enhances antigen presentation by dendritic cells and antigen-specific anti-tumor immunity. Nat Biotechnol 2004; 22:1546 - 53; http://dx.doi.org/10.1038/nbt1035; PMID: 15558048
   PubMed Web of Science ®Google Scholar
• Yen MC, Lin CC, Chen YL, Huang SS, Yang HJ, Chang CP, et al. A novel cancer therapy by skin delivery of indoleamine 2,3-dioxygenase siRNA. Clin Cancer Res 2009; 15:641 - 9; http://dx.doi.org/10.1158/1078-0432.CCR-08-1988; PMID: 19147770
   PubMed Web of Science ®Google Scholar
• Huang TT, Yen MC, Lin CC, Weng TY, Chen YL, Lin CM, et al. Skin delivery of short hairpin RNA of indoleamine 2,3 dioxygenase induces antitumor immunity against orthotopic and metastatic liver cancer. Cancer Sci 2011; 102:2214 - 20; http://dx.doi.org/10.1111/j.1349-7006.2011.02094.x; PMID: 21899659
   PubMed Web of Science ®Google Scholar
• Riley JL, June CH. The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation. Blood 2005; 105:13 - 21; http://dx.doi.org/10.1182/blood-2004-04-1596; PMID: 15353480
   PubMed Web of Science ®Google Scholar
• Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited. Annu Rev Immunol 2005; 23:515 - 48; http://dx.doi.org/10.1146/annurev.immunol.23.021704.115611; PMID: 15771580
   PubMed Web of Science ®Google Scholar
• Dejean AS, Beisner DR, Ch’en IL, Kerdiles YM, Babour A, Arden KC, et al. Transcription factor Foxo3 controls the magnitude of T cell immune responses by modulating the function of dendritic cells. Nat Immunol 2009; 10:504 - 13; http://dx.doi.org/10.1038/ni.1729; PMID: 19363483
   PubMed Web of Science ®Google Scholar